ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Eye infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
2,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
3,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
5,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
6,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
8,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
8,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
9,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
9,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
10,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
12,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
13,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
13,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
14,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
16,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
17,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
17,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
18,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
19,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
20,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
21,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
23,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
24,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
24,2,Headache,Headaches NEC,Headaches,Nerv,N
24,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
25,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
26,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
26,4,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
27,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
28,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
28,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
29,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
30,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
31,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
32,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,1,Cerebral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
33,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
33,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
33,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
33,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,6,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
33,7,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
33,8,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
33,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
33,10,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
33,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
33,12,Intracardiac mass,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
33,13,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
33,14,Noninfective encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
33,15,Oral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
33,16,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,17,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
33,18,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
33,19,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
33,20,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
34,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
35,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
36,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
36,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
38,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
39,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
40,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
41,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
42,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
43,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
44,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
44,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
44,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
46,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
50,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
50,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
